Naheed Ansari is a Nephrology physician affiliated with New York City Health and Hospitals Corporation. OpenAlex indexes 28 publications with 1,054 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Pelham Pkwy S
Bronx, NY 104611138
Telephone
718-918-3060Registry record last updated 29 Oct 2019.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SCPHARMACEUTICALS INC.Program year20251 payment
- Amgen Inc.Program year20252 payments
- Travere Therapeutics, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
41%Calcium channel blocker20.1%Nifedipine Er56%Amlodipine Besylate44%Part D<11 patientsStatin14.2%Atorvastatin Calcium65%Simvastatin35%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
19.2%Proton pump inhibitor13.8%Pantoprazole Sodium61%Omeprazole39%Part D<11 patientsH2 blocker5.4%Famotidine100%Part D<11 patientsOther
18.4%Phosphate Binder13.8%Sevelamer Carbonate100%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia4.6%Velphoro100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Acute Renal Infarction Caused by Renal Arteriovenous Fistula in a Patient with Fibromuscular Dysplasia: A Rare Case Report
Journal of the American Society of Nephrology
2025 - Comparison of Rates of AKI Between Two COVID-19 Surges in Hospitalized Patients in the Bronx
Journal of the American Society of Nephrology
2021 - Urinary Biomarkers and Progression of AKI in Patients with Cirrhosis
Clinical Journal of the American Society of Nephrology
2014 - Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury
International Journal of Nephrology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Shoshana Marmon, MD
New York City Health and Hospitals Corporation
Stephen Kuperberg, MD
New York City Health and Hospitals Corporation
Bijan Safai, MD
New York City Health and Hospitals Corporation
Joan Reibman, MD
New York City Health and Hospitals Corporation
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”